Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jan 21, 2008; 14(3): 421-427
Published online Jan 21, 2008. doi: 10.3748/wjg.14.421
Published online Jan 21, 2008. doi: 10.3748/wjg.14.421
Table 2 Correlation of integrin β3 mRNA, VEGF protein and MVD with survival period
| Groups | n | Mean survival period (mo) | t | P | 5-yr survival rate (%) | χ2 | P | |
| Integrin β3 mRNA | - | 56 | 38.46 ± 29.20 | 2.27 | < 0.05 | 71.4 (40/56) | 5.60 | < 0.05 |
| + - +++ | 62 | 27.18 ± 24.73 | 11.3 (7/62) | |||||
| VEGF | - | 54 | 41.70 ± 30.62 | 3.40 | < 0.01 | 70.4 (16/54) | 6.52 | < 0.05 |
| + - +++ | 64 | 24.80 ± 21.78 | 10.9 (7/64) | |||||
| MVD (n/mm2) | < 54.90 | 47 | 44.70 ± 32.05 | 3.84 | < 0.01 | 63.8 (17/47) | 13.85 | < 0.01 |
| ≥ 54.90 | 71 | 24.48 ± 20.40 | 8.5 (6/71) |
- Citation: Li SG, Ye ZY, Zhao ZS, Tao HQ, Wang YY, Niu CY. Correlation of integrin β3 mRNA and vascular endothelial growth factor protein expression profiles with the clinicopathological features and prognosis of gastric carcinoma. World J Gastroenterol 2008; 14(3): 421-427
- URL: https://www.wjgnet.com/1007-9327/full/v14/i3/421.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.421